For press inquiries click here to contact us.
FierceBiotech
Intellia gears up for human testing of CRISPR with new HQ, set to double staffers
The Boston Globe
Intarcia seeks approval of drug-device combo to treat Type 2 diabtes
Fortune
A New Innovation for Type 2 Diabetes
Bloomberg
Nestle Pays $145 Million for Stake in Biotech Firm Aimmune
Reuters
AstraZeneca licenses respiratory drug to Insmed
FierceBiotech
FierceBiotech’s Fierce 15 for 2016: Arcus Biosciences
StreetInsider.com
Epizyme (EPZM) Announces Earning $6M Milestone Related to GSK3326595 Phase 1
Fortune
Diabetes ‘Unicorn’ Raises Final VC Round Before IPO
StreetInsider.com
Aerie Pharma (AERI) PT Raised to $52 at Needham & Company as Roclatan Knocks It Out of the Park
Please see important disclaimers in the Terms section.
